PRNewswire
IRVING, Texas
(NASDAQ-OTCBB:RBCL)
IRVING, Texas, June 22 /PRNewswire-FirstCall/
-- RBC Life Sciences, Inc., (OTCBulletinBoard: RBCL) a provider of
proprietary nutritional supplements and wound care/pain management
products, announced today that the company's flagship antioxidant,
Microhydrin, "significantly" reduced lactic acid buildup and improved
hydration in horses during strenuous exercise.
The
three-week Rutgers University study corroborates more than a dozen
anecdotal and clinical studies that show the uniquely formulated
Microhydrin antioxidant reduces lactic buildup, improves hydration and
increases blood oxygen levels in humans.
"This
and previous clinical trials prove that Microhydrin antioxidant has
some very distinct and significant benefits to humans and animals
participating in strenuous exercise or competition," said RBC Life
Sciences' CEO and President John W. Price. "Studies have shown that
lactic acid buildup can contribute to muscular acidosis and may inhibit
optimal performance."
Conducted
by the Equine Science Center at Rutgers, the horse trial measured blood
lactate levels and weight loss of mares. During the week preceding
exercise, half of the mares received Microhydrin antioxidant in their
morning feed while the others received feed without the nutritional
supplement. At the end of this weeklong preparation, all the mares
underwent a standard exercise test on an equine treadmill. The equine
center later switched the control group of mares and retested.
The
study found that the mares who received Microhydrin antioxidant in
their feed had more than 13% lower blood lactate levels when they
reached a fatigued state. The lactate levels were nearly 15% less up to
30-minutes after exercise. A similar study in human cyclists undergoing
an endurance test showed a nearly 24% reduction in blood lactate
concentration.
The
mares fed Microhydrin antioxidant also lost less water weight during
exercise, according to the study. Similarly, the human study showed
that the cyclists maintained a better state of hydration after
strenuous exercise.
Microhydrin's
unique hydration characteristics stem from its unique composition of
silica, potassium, magnesium and vitamin C. The antioxidant's colloidal
silicate minerals display a variety of properties, including an
increase in surface area--bonding absorbed water as well as minerals.
Specific silicate interactions play a substantial role in nutrient
bioavailability by enhancing solubility properties, improving ion and
water transport and also providing free radical antioxidant protection.
About RBC Life SciencesRBC
Life Sciences develops, manufactures and markets high-quality
nutritional supplements and personal care products to a growing
population of consumers seeking wellness and a healthy lifestyle. Under
its MPM Medical
brand, RBC Life Sciences also develops and markets to health care
professionals in the United States proprietary prescription and
nonprescription products for advanced wound care and pain management.
All products are tested for quality assurance in-house, and by outside
independent laboratories, to comply with regulations in the U.S. and in
more than 30 countries in which the products are distributed. For more
information, visit the Company's Web site at www.rbclifesciences.com.
The
statements above, other than statements of historical fact, may be
forward-looking. Actual events will be dependent upon a number of
factors and risks including, but not limited to, changes in plans by
the Company's management, delays or problems in production, changes in
the regulatory process, changes in market trends, and a number of other
factors and risks described from time to time in the Company's filings
with the Securities and Exchange Commission.
SOURCE: RBC Life Sciences, Inc.
Web site: http://www.rbclifescience.com/